<DOC>
	<DOCNO>NCT02305836</DOCNO>
	<brief_summary>A prospective block randomize control trial aim assess EA effective donepezil improve cognitive function AD patient . The hypothesis study follow : - Is short-term effect electroacupuncture well donepezil improve cognitive function patient Alzheimer 's disease 12 week ' treatment ? - Whether effect electroacupuncture improve cognitive function last end 6 month ' follow-up ?</brief_summary>
	<brief_title>Effect Electroacupuncture Treating Alzheimer 's Disease</brief_title>
	<detailed_description>- Patient registry : Participants experience cognitive impairment recruit recruited Guang'anmen Hospital , Beijing , China , via poster . A neurologist make diagnosis . Randomization perform pharmacological assessment center Guang'anmen Hospital . - Sample size : The calculation sample size base primary outcome change total MMSE score baseline week 12 . According previous study ( H. Feldman , S. Gauthier , J. Hecker , et al. , `` A 24-week , randomize , double-blind study donepezil moderate severe Alzheimer 's disease , '' Neurology , vol . 57 , pp . 613-620 , 2001 ) MMSE score improve baseline donepezil mean 1.79 point standard deviation 3.24 12 week . Based minimum clinically important difference ( MCID ) MMSE scale , 1.4 point , ( R. Howard , P. Phillips , T. Johnson , et al. , `` Determining minimum clinically important difference outcomes DOMINO trial '' , Int J Geriatr Psychiatry , vol . 26 , pp . 812-817 , 2011 ) estimate change mean score 3.21 standard deviation 1.33 baseline EA MMSE score 12 week follow-up . The total sample size require study 160 ( 80 group ) , alpha risk 5 % beta risk 10 % . 80-100 participant need provide 80 % power detect difference 1.4 change MMSE two group significance level 5 % use analysis variance , assume 10 % loss follow-up . - Quality control 1 . Investigators participate trial take strict course process randomization , manipulation electroacupuncture , selection patient , whole process trial request fill case report form order improve internal consistency observation different researcher . 2 . The process randomization rigorous control . 3 . This trial specific inclusion exclusion criterion . 4 . Both outcome assessor statistician blind . 5 . Patients sign inform consent voluntarily good relationship researcher patient establish order improve patient ' compliance . Participants detail record contact information easy follow-up . 6 . The standard drug , acupuncture apparatus , inspection equipment consistent patient two group . - Outcome assessment , completion case report form data management rigorous supervision .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Participants meet follow criterion include trial : 1 ) diagnostic criterion Neurological Communicative Disorders Stroke Alzheimer Disease Related Disorders Association ( NINCDSADRDA ) Operational Criteria Diagnosis Alzheimer 's disease ( OCDAD ) , 2 ) age 6085 year , 3 ) cognitive impairment base score Chinese version Mini Mental State Examination ( MMSE ) ( illiteracy group ≤19 , primary school group ≤22 , junior high school high school group ≤23 , welleducated group ≤26 ) , 4 ) absence depression ( via emotional assessment ) , 5 ) Magnetic Resonance Imaging ( MRI ) confirmation atrophy hippocampus medial temporal lobe volume , 6 ) Medial Temporal Lobe Atrophy Rating Scale ( MTAscale ) score ( ≥ 2 75 year , ≥ 3 75 year ) . Exclusion criterion : Participants meet one follow criterion exclude trial : 1 ) Cognitive impairment cause factor ( e.g . vascular dementia , dementia Lewy 's body , frontotemporal dementia , hormone metabolic abnormality , hypothyroidism , folic acid vitamin B12 deficiency , delirium mental emotional disorder [ schizophrenia depression ] ) , 2 ) serious heart condition , hepatic disease , renal system disease , hematopoietic system disease , malnutrition whole body , 3 ) aphasia decrease vision severe , blindness , disturbance consciousness , participant cooperate related examination due physical disability , 4 ) anticoagulant treatment warfarin heparin , 5 ) use pacemaker participant afraid acupuncture , 6 ) acupuncture donepezil treatment past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Electroacupuncture</keyword>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>alzheimer</keyword>
	<keyword>cognitive impairment</keyword>
</DOC>